PL3119783T3 - Inhibitory kinazy 1 oddziałującej z adaptorem, kompozycje je zawierające i sposoby ich zastosowania - Google Patents
Inhibitory kinazy 1 oddziałującej z adaptorem, kompozycje je zawierające i sposoby ich zastosowaniaInfo
- Publication number
- PL3119783T3 PL3119783T3 PL15712026T PL15712026T PL3119783T3 PL 3119783 T3 PL3119783 T3 PL 3119783T3 PL 15712026 T PL15712026 T PL 15712026T PL 15712026 T PL15712026 T PL 15712026T PL 3119783 T3 PL3119783 T3 PL 3119783T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- compositions
- methods
- associated kinase
- adapter associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461953976P | 2014-03-17 | 2014-03-17 | |
| PCT/US2015/020696 WO2015142714A1 (en) | 2014-03-17 | 2015-03-16 | Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use |
| EP15712026.2A EP3119783B1 (en) | 2014-03-17 | 2015-03-16 | Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3119783T3 true PL3119783T3 (pl) | 2021-01-11 |
Family
ID=52727478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15712026T PL3119783T3 (pl) | 2014-03-17 | 2015-03-16 | Inhibitory kinazy 1 oddziałującej z adaptorem, kompozycje je zawierające i sposoby ich zastosowania |
| PL20177604T PL3719021T3 (pl) | 2014-03-17 | 2015-03-16 | Inhibitory kinazy 1 związanej z adapterem, kompozycje je zawierające, oraz sposoby ich zastosowania |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20177604T PL3719021T3 (pl) | 2014-03-17 | 2015-03-16 | Inhibitory kinazy 1 związanej z adapterem, kompozycje je zawierające, oraz sposoby ich zastosowania |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9682982B2 (enExample) |
| EP (2) | EP3119783B1 (enExample) |
| JP (1) | JP6553081B2 (enExample) |
| CN (1) | CN106103447B (enExample) |
| AR (1) | AR099766A1 (enExample) |
| AU (1) | AU2015231672B2 (enExample) |
| CA (1) | CA2941870C (enExample) |
| DK (2) | DK3719021T3 (enExample) |
| ES (2) | ES2821441T3 (enExample) |
| HU (1) | HUE050975T2 (enExample) |
| PL (2) | PL3119783T3 (enExample) |
| PT (2) | PT3119783T (enExample) |
| TW (1) | TW201620911A (enExample) |
| WO (1) | WO2015142714A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2834243T3 (pl) * | 2012-03-09 | 2018-09-28 | Lexicon Pharmaceuticals, Inc. | Związki na bazie pirazolo[1,5-a]pirymidyny, zawierające je kompozycje i sposoby ich zastosowania |
| ES2678877T3 (es) | 2013-10-11 | 2018-08-20 | Bristol-Myers Squibb Company | Inhibidores de pirrolotriazina quinasa |
| CN109369576B (zh) * | 2018-09-19 | 2020-11-27 | 上海凌凯医药科技有限公司 | 一种合成3-甲基氧杂环丁烷-3-(4-硝基苯基)碳酸酯的方法 |
| CA3175973A1 (en) * | 2020-04-21 | 2021-10-28 | Lexicon Pharmaceuticals, Inc. | 4-(3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)piperazine for use in the the treatment of cov-229e or cov-oc43 coronaviruses infections |
| US11730723B2 (en) | 2020-04-21 | 2023-08-22 | Lexicon Pharmaceuticals, Inc. | Compounds and methods for treating viral infections |
| WO2023196584A2 (en) * | 2022-04-08 | 2023-10-12 | New York University | Endocytosis inhibitors and their use for pain treatment |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| US6194410B1 (en) * | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
| EP1873157A1 (en) * | 2006-06-21 | 2008-01-02 | Bayer Schering Pharma Aktiengesellschaft | Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| WO2010118207A1 (en) * | 2009-04-09 | 2010-10-14 | Schering Corporation | Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors |
| UA110324C2 (en) * | 2009-07-02 | 2015-12-25 | Genentech Inc | Jak inhibitory compounds based on pyrazolo pyrimidine |
| WO2011030139A1 (en) * | 2009-09-11 | 2011-03-17 | Astrazeneca Ab | 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
| EP2523552B1 (en) * | 2010-01-14 | 2015-05-13 | Merck Sharp & Dohme Corp. | Pyrazolo[1,5-a]pyrimidines as mark inhibitors |
| WO2012034095A1 (en) * | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| HUE036040T2 (hu) * | 2012-03-09 | 2018-06-28 | Lexicon Pharmaceuticals Inc | Adaptor-asszociált kináz 1 gátlása fájdalom kezelésére |
| PL2834243T3 (pl) * | 2012-03-09 | 2018-09-28 | Lexicon Pharmaceuticals, Inc. | Związki na bazie pirazolo[1,5-a]pirymidyny, zawierające je kompozycje i sposoby ich zastosowania |
| WO2013134219A1 (en) * | 2012-03-09 | 2013-09-12 | Lexicon Pharmaceuticals, Inc. | Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof |
-
2015
- 2015-03-04 TW TW104106872A patent/TW201620911A/zh unknown
- 2015-03-16 AU AU2015231672A patent/AU2015231672B2/en active Active
- 2015-03-16 PL PL15712026T patent/PL3119783T3/pl unknown
- 2015-03-16 PT PT157120262T patent/PT3119783T/pt unknown
- 2015-03-16 US US14/658,653 patent/US9682982B2/en active Active
- 2015-03-16 JP JP2016557251A patent/JP6553081B2/ja active Active
- 2015-03-16 CN CN201580014255.6A patent/CN106103447B/zh active Active
- 2015-03-16 HU HUE15712026A patent/HUE050975T2/hu unknown
- 2015-03-16 AR ARP150100787A patent/AR099766A1/es unknown
- 2015-03-16 EP EP15712026.2A patent/EP3119783B1/en active Active
- 2015-03-16 WO PCT/US2015/020696 patent/WO2015142714A1/en not_active Ceased
- 2015-03-16 ES ES15712026T patent/ES2821441T3/es active Active
- 2015-03-16 PL PL20177604T patent/PL3719021T3/pl unknown
- 2015-03-16 PT PT201776044T patent/PT3719021T/pt unknown
- 2015-03-16 DK DK20177604.4T patent/DK3719021T3/da active
- 2015-03-16 EP EP20177604.4A patent/EP3719021B1/en active Active
- 2015-03-16 ES ES20177604T patent/ES2911388T3/es active Active
- 2015-03-16 CA CA2941870A patent/CA2941870C/en active Active
- 2015-03-16 DK DK15712026.2T patent/DK3119783T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| TW201620911A (zh) | 2016-06-16 |
| PT3719021T (pt) | 2022-04-08 |
| AR099766A1 (es) | 2016-08-17 |
| AU2015231672A1 (en) | 2016-09-15 |
| US20160039824A1 (en) | 2016-02-11 |
| WO2015142714A1 (en) | 2015-09-24 |
| ES2911388T3 (es) | 2022-05-19 |
| JP2017507980A (ja) | 2017-03-23 |
| DK3719021T3 (da) | 2022-06-13 |
| EP3119783A1 (en) | 2017-01-25 |
| ES2821441T3 (es) | 2021-04-26 |
| CN106103447A (zh) | 2016-11-09 |
| EP3719021A1 (en) | 2020-10-07 |
| PL3719021T3 (pl) | 2022-06-20 |
| EP3719021B1 (en) | 2022-03-09 |
| PT3119783T (pt) | 2020-09-24 |
| US9682982B2 (en) | 2017-06-20 |
| JP6553081B2 (ja) | 2019-07-31 |
| CN106103447B (zh) | 2019-07-16 |
| HK1226065A1 (zh) | 2017-09-22 |
| DK3119783T3 (da) | 2020-09-28 |
| EP3119783B1 (en) | 2020-06-24 |
| CA2941870C (en) | 2022-07-19 |
| HUE050975T2 (hu) | 2021-01-28 |
| CA2941870A1 (en) | 2015-09-24 |
| AU2015231672B2 (en) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3277681T1 (sl) | Imidazolonilkinolini in njihova uporaba kot inhibitorji ATM-kinaze | |
| HUE056172T2 (hu) | Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra | |
| ZA201700786B (en) | Protein kinase c inhibitors and methods of their use | |
| ZA201700021B (en) | Alk kinase inhibitor, and preparation method and use thereof | |
| ZA202005857B (en) | Oligonucleotide compositions and methods of making the same | |
| EP3190886A4 (en) | Compositions and methods of use thereof | |
| PT3119783T (pt) | Inibidores de quinase associada a adaptadores 1, composições que os compreendem e métodos para sua utilização | |
| PL3113774T3 (pl) | Kompozycje grapiprantu i sposoby ich zastosowania | |
| IL258690A (en) | Pyridone derivatives and their use as kinase inhibitors | |
| EP3207029A4 (en) | Tryptamide compositions and methods of use | |
| IL261794A (en) | Preparations and methods for using them | |
| IL247645A0 (en) | Preparations of seleno-organic compounds and methods of using them | |
| GB201609580D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201705201D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201509381D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201409661D0 (en) | Novel compounds and their use as kinase inhibitors | |
| GB201405532D0 (en) | Novel compounds and their use as Kinase inhibitors | |
| GB201505460D0 (en) | Novel compounds and their use as kinase inhibitors | |
| AU2014905067A0 (en) | Compositions and methods of use | |
| AU2014902829A0 (en) | Compositions and Methods of Use |